The increase in price target by Goldman Sachs suggests a more optimistic valuation of Eastman Chemical's stock, which could lead to increased investor confidence and a potential short-term rise in the stock price. The Neutral rating indicates that the stock is adequately valued at current levels, but the raised target implies that there may be some room for growth.